Hepato-pancreatectomy: how morbid? Results from the national surgical quality improvement project

HPB (Oxford). 2015 Sep;17(9):763-9. doi: 10.1111/hpb.12426. Epub 2015 Jun 8.

Abstract

Background: Simultaneous resection of both the liver and the pancreas carries significant complexity. The objective of this study was to investigate peri-operative outcomes after a synchronous hepatectomy and pancreatectomy (SHP).

Methods: The American College of Surgeons National Surgical Quality Improvement Project database was queried to identify patients who underwent SHP. Resections were categorized as '< hemihepatectomy', '≥ hemihepatectomy' (hemihepatectomy and trisectionectomy), 'PD' (pancreaticoduodenectomy and total pancreatectomy) and 'distal' (distal pancreatectomy and enucleation).

Results: From 2005 to 2013, 480 patients underwent SHP. Patients were stratified based on the extent of resection: '< hemihepatectomy + distal (n = 224)', '≥ hemihepatectomy + distal' (n = 49), '< hemihepatectomy + PD' (n = 83) and '≥ hemihepatectomy + PD' (n = 24). Although the first three groups had a reasonable and comparable safety profile (morbidity 33-51% and mortality 0-6.6%), the '≥ hemihepatectomy + PD' group was associated with an 87.5% morbidity (organ space infection 58.3%, re-intubation 12.5%, reoperation 25% and septic shock 25%), 8.3% 30-day mortality and 18.2% in-hospital mortality.

Conclusions: A synchronous hemihepatectomy (or trisectionectomy) with PD remains a highly morbid combination and should be reserved for patients who have undergone extremely cautious selection.

Publication types

  • Multicenter Study

MeSH terms

  • Adult
  • Aged
  • Aged, 80 and over
  • Female
  • Hepatectomy / standards*
  • Hospital Mortality / trends
  • Humans
  • Liver Diseases / complications
  • Liver Diseases / surgery*
  • Male
  • Middle Aged
  • Morbidity / trends
  • Pancreatectomy / standards*
  • Pancreatic Diseases / complications
  • Pancreatic Diseases / surgery*
  • Postoperative Complications / epidemiology*
  • Quality Improvement*
  • Retrospective Studies
  • Survival Rate / trends
  • Treatment Outcome
  • United States / epidemiology
  • Young Adult